Literature DB >> 27642850

Percutaneous Transhepatic Cholangioscopy in Bilioenteric Anastomosis Stricture.

Hyoung-Chul Oh1.   

Abstract

Bilioenteric anastomosis strictures are a serious complication of biliary surgery, and often result in recurrent cholangitis, choledocholithiasis, biliary cirrhosis, and hepatic failure. Bilioenteric reconstructive surgery is the standard treatment of choice for such complications. However, percutaneous transhepatic cholangioscopy (PTCS), also known as per-oral endoscopic-guided intervention, is a less invasive procedure that is becoming an increasingly popular alternative. This review describes the PTCS procedure (including the preparation process), as well as the diagnostic and therapeutic role of PTCS in bilioenteric anastomosis strictures.

Entities:  

Keywords:  Anastomosis; Cholangioscopy; Constriction, pathologic

Year:  2016        PMID: 27642850      PMCID: PMC5152783          DOI: 10.5946/ce.2016.125

Source DB:  PubMed          Journal:  Clin Endosc        ISSN: 2234-2400


INTRODUCTION

Bilioenteric anastomosis strictures may be caused by benign conditions such as postoperative fibrotic change and scarring, or malignant conditions such as tumor recurrence [1-3]. They are a serious complication of biliary surgery, and may result in recurrent cholangitis, choledocholithiasis, biliary cirrhosis, and hepatic failure. Bilioenteric reconstructive surgery is performed for patients with bilioenteric anastomosis stricture complications. However, this surgery is difficult to perform, and its success rate decreases with each successive surgery [2,4-7]. The percutaneous transhepatic cholagioscopy (PTCS) or peroral endoscopy-guided intervention is less invasive procedure that has become an increasingly popular alternative for managing bilioenteric anastomostic strictures. With the increase in the number of liver transplantations—especially living-donor transplantations—over the last few decades, the therapeutic role of PTCS has become even more important.

PROCEDURES

PTCS-guided interventions are laborious procedures, which require multi-step preparation before cholangioscopic intervention can be performed. First, percutaneous transhepatic biliary drainage (PTBD) is performed with an 8.5-Fr catheter inserted under fluoroscopic guidance into the right posterior branch or left peripheral branch of the intrahepatic duct, based on a planned anatomical approach to the stricture. Two or 3 days after PTBD, the percutaneous tract is dilated to allow for the passage of the cholangioscope. This is usually done by one-stage dilation (e.g., from 8.5 to 16 or 18 Fr) or stepwise dilation in two sessions. For sinus tract maturation, a 16- or 18-Fr PTC catheter is placed at least 7 days before cholangioscopy. Cholangioscopy is then performed using a 5-mm diameter cholangioscope [8,9]. Procedure-related complications tend to occur during PTBD insertion (12.9%), tract dilation (12.8%), and tract maturation (6.9%). Cholangitis and bacteremia are the most frequent complications. The incidence of complications for therapeutic cholangioscopies has been reported to be 6.7%, of which cholangitis and bile duct injuries are the commonest complications [9].

CHOLANGIOSCOPY

Diagnostic role

It is essential to be able to diagnose a bilioenteric anastomosis stricture accurately, because the choice of treatment depends on whether the cause is benign or malignant. Tissue acquisition is the mainstay of diagnosis. However, in bilioenteric anastomosis strictures, access is limited by the surgically altered anatomy and the limited visualization of the stricture site via a retrograde approach. As such, it is almost impossible to obtain a tissue sample with endoscopic retrograde cholangiopancreatography or single (or double) balloon enteroscopy. Instead, PTCS can play an important diagnostic role by allowing the direct visual inspection of a bilioenteric anastomotic lesion in an antegrade approach [10]. The typical cholangioscopic findings of a benign biliary stricture include the following: smooth mucosal surface, tapered luminal narrowing, short stricture segment (accompanying stones), and the absence of definite neovascularization (tumor vessel) [11]. A tumor vessel is an abnormally proliferating and tortuous vascular structure on the bile duct mucosa, and is one of the defining characteristics of biliary malignancy (Fig. 1) [12]. PTCS-guided target biopsies allow the direct visualization of tumor vessels. They were found to improve diagnostic accuracy significantly, especially in infiltrative cholangiocarcinoma. They had a sensitivity of 96%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 91% [12].
Fig. 1.

Cholangioscopy image shows malignant tumor vessels at the biliary stricture site.

Therapeutic role

PTCS has several advantages over percutaneous cholangiography-guided interventions in treating bilioenteric anastomosis strictures. Due to the presence of bile stasis and remnant suture materials, postoperative bilioenteric anastomosis strictures are often complicated by bile duct stones. Large stones proximal to the stricture site can be easily fragmented with electrohydraulic shock-wave lithotripsy or laser lithotripsy, and then removed during stricture dilation. In addition, since remnant suture materials or surgical clips can act as niduses for stone formation, it is essential to remove any foreign bodies present at the bilioenteric anastomosis stricture site [13,14]. The main role of PTCS in bilioenteric anastomosis strictures is the recanalization and dilation of the strictures. Due to postoperative fibrosis and scarring, the strictures are often pinpoints (Fig. 2). PTCS guides the targeted recanalization with a guidewire or needle-knife [15,16]. The initial technical success rate was reported as 100%; however, the recurrence rate was 38% at a mean of 17 months. The overall success rate after repeated dilation was 82% after a mean follow-up period of 33 months, and the 5-year cumulative patency rate was 48%. There were no significant correlations between recurrence rate and the duration of catheter maintenance or number of sessions required [17].
Fig. 2.

(A) Cholangiography images show a bilioenteric anastomosis stricture and a marked proximal dilatation of the bile duct. (B) A pinpoint stricture (arrow) was recanalized by guide wire manipulation. (C) Balloon dilation was performed. Adapted from Yang et al. [15].

One drawback of PTCS is that the working channel has a small diameter, and as such, a self-expandable metal stent cannot be placed through it. One study compared the temporary percutaneous placement of retrievable fully-covered metal stents with percutaneous balloon dilation in patients with benign biliary strictures. It found that the patency rates were significantly better in the metal stent group than in the balloon dilation group at 3 years (87% vs. 44%, p=0.022). The indwelling period of the PTBD catheter after the initial procedure was also shorter in the metal stent group (2.5 months vs. 4.5 months, p=0.001) [18]. PTCS is also useful in managing intractable bilioenteric strictures after balloon dilation. Although the evidence is limited to case reports, steroids (triamcinolone) can be injected directly into strictures refractory to treatment with balloon dilation and indwelling catheters [19]. For cases in which conventional methods for recanalization and/or dilation fail, PTCS can be used to guide the correct placement of magnets into the stricture site. Magnetic compression anastomosis was reported to be successful in 15 of 19 patients who had treatment-refractory benign biliary strictures or duct-to-duct anastomosis strictures after liver transplantation. Recanalization was achieved and maintained in all 15 patients at 1 year postprocedure [20,21].

CONCLUSIONS

Despite the laborious preparations required, PTCS has an important role to play in the management of bilioenteric anastomosis strictures.
  20 in total

1.  Temporary placement of retrievable fully covered metallic stents versus percutaneous balloon dilation in the treatment of benign biliary strictures.

Authors:  Jin Hyoung Kim; Dong Il Gwon; Gi-Young Ko; Kyu-Bo Sung; Sung Koo Lee; Hyun-Ki Yoon; Ji Hoon Shin; Ho-Young Song
Journal:  J Vasc Interv Radiol       Date:  2011-04-22       Impact factor: 3.464

2.  Management of strictures of the biliary tract.

Authors:  K W Warren; J C Mountain; A I Midell
Journal:  Surg Clin North Am       Date:  1971-06       Impact factor: 2.741

Review 3.  Surgical clips as a nidus for biliary stone formation: diagnosis and therapy.

Authors:  J Martinez; W Combs; P G Brady
Journal:  Am J Gastroenterol       Date:  1995-09       Impact factor: 10.864

4.  Recurrent biliary stricture. Patterns of recurrence and outcome of surgical therapy.

Authors:  C A Pellegrini; M J Thomas; L W Way
Journal:  Am J Surg       Date:  1984-01       Impact factor: 2.565

5.  Non-absorbable suture material as a nidus for the formation of common bile duct stones.

Authors:  B Bak; J Ornsholt
Journal:  Ann Chir Gynaecol       Date:  1985

6.  Recanalization of refractory benign biliary stricture using magnetic compression anastomosis.

Authors:  Sung Ill Jang; Kwangwon Rhee; Haewon Kim; Yong Hoon Kim; Jieun Yun; Kwang-Hun Lee; Seungmin Bang; Jae Bok Chung; Dong Ki Lee
Journal:  Endoscopy       Date:  2013-11-19       Impact factor: 10.093

7.  The long-term outcome of hepaticojejunostomy in the treatment of benign bile duct strictures.

Authors:  A Tocchi; G Costa; L Lepre; G Liotta; G Mazzoni; A Sita
Journal:  Ann Surg       Date:  1996-08       Impact factor: 12.969

8.  Tumor vessel: a valuable cholangioscopic clue of malignant biliary stricture.

Authors:  H J Kim; M H Kim; S K Lee; K S Yoo; D W Seo; Y I Min
Journal:  Gastrointest Endosc       Date:  2000-11       Impact factor: 9.427

9.  Long-term results of hepaticojejunostomy for benign lesions of the bile ducts.

Authors:  M A Röthlin; M Löpfe; R Schlumpf; F Largiadèr
Journal:  Am J Surg       Date:  1998-01       Impact factor: 2.565

10.  Analysis of percutaneous transhepatic cholangioscopy-related complications and the risk factors for those complications.

Authors:  H-C Oh; S K Lee; T Y Lee; S Kwon; S S Lee; D-W Seo; M-H Kim
Journal:  Endoscopy       Date:  2007-08       Impact factor: 10.093

View more
  7 in total

Review 1.  Indications for Single-Operator Cholangioscopy and Pancreatoscopy: an Expert Review.

Authors:  Enrique Pérez-Cuadrado-Robles; Pierre H Deprez
Journal:  Curr Treat Options Gastroenterol       Date:  2019-09

2.  Endoscopic biliary therapy in the era of bariatric surgery.

Authors:  Harry Martin; Tareq El Menabawey; Orla Webster; Constantinos Parisinos; Michael Chapman; Stephen P Pereira; Gavin Johnson; George Webster
Journal:  Frontline Gastroenterol       Date:  2021-02-24

Review 3.  Endoscopic management of anastomotic stricture after living-donor liver transplantation.

Authors:  Dong Wook Lee; Jimin Han
Journal:  Korean J Intern Med       Date:  2019-02-25       Impact factor: 2.884

4.  Cholangiolithiasis postliver transplantation: Successful treatment utilizing percutaneous transhepatic cholangioscopy and laser lithotripsy.

Authors:  Nariman Nezami; Liliya Benchetrit; Igor Latich; Todd Schlachter
Journal:  Radiol Case Rep       Date:  2019-10-08

5.  Biliary complications in recipients of living donor liver transplantation: A single-centre study.

Authors:  Reginia Nabil Guirguis; Ehab Hasan Nashaat; Azza Emam Yassin; Wesam Ahmed Ibrahim; Shereen A Saleh; Mohamed Bahaa; Mahmoud El-Meteini; Mohamed Fathy; Hany Mansour Dabbous; Iman Fawzy Montasser; Manar Salah; Ghada Abdelrahman Mohamed
Journal:  World J Hepatol       Date:  2021-12-27

6.  Minimally invasive treatment of intrahepatic cholangiolithiasis after stricture of hepaticojejunal anastomosis.

Authors:  Aliaksandr Varabei; Yury Arlouski; Natalli Lagodich; Vitaly Arehay
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2018-01-10       Impact factor: 1.195

7.  Efficacy and Safety of Percutaneous Transhepatic Cholangioscopy with the Spyglass DS Direct Visualization System in Patients with Surgically Altered Anatomy: A Pilot Study.

Authors:  Hyung Ku Chon; Keum Ha Choi; Sang Hyun Seo; Tae Hyeon Kim
Journal:  Gut Liver       Date:  2022-01-15       Impact factor: 4.519

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.